Filter
18
Text search:
Zaman
MM
Featured
Recommendations
1
New Publications
7
Language
Document type
No document type
8
Manuals
4
Studies & Reports
4
Guidelines
2
Countries / Regions
Bangladesh
4
Cameroon
1
Nepal
1
Asia
1
Authors & Publishers
Publication Years
Category
Countries
7
Women & Child Health
4
Clinical Guidelines
3
Key Resources
1
Toolboxes
COVID-19
5
Cholera
3
Natural Hazards
1
HIV
1
Planetary Health
1
NTDs
1
Chronic Dis Int - Volume 3 Issue 1 - 2016
ISSN 2379-7983
Special issue: WHO South-East Asia Journal of Public Health -Vol. 5, Issue 1, April 2016.This special This issue contains a rich collection of articles, demonstrating the encouraging scientific momentum to address the growing burden of diabetes in the region
Cholera is an acute diarrhoeal disease caused by the ingestion of food or water contaminated with the bacterium V.
cholerae. It has a short incubation period of a few hours to 5 days. It is endemic in some countries, frequently
showing seasonal variations in the number of reported cases. Cholera a
...
BMC Health Services Research (2019) 19:458 https://doi.org/10.1186/s12913-019-4315-7
Globalization and Health (2021) 17:74 https://doi.org/10.1186/s12992-021-00722-3
Parasites & Vectors volume 15, Article number: 389 (2022)
Dengue is one of the common arboviral infections and is a public health problem in South East Asia. The aim of this systematic review and meta-analysis was to evaluate the prevalence and distribution of dengue in SAARC (South Asian Associ
...
This paper presents lessons learned from previous flood responses in developing countries, based on a structured review of the literature. It is intended for people working in relief and recovery operations who have to decide if, when and how to intervene after a flood.
BMC Health Services Research (2017) 17:623 DOI 10.1186/s12913-017-2567-7
PLOS Medicine | DOI:10.1371/journal.pmed.1002088 August 23, 2016
Um Manual Passo A Passo
Um Manual Passo A Passo
Um Manual Passo A Passo
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
